Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lazo

Showing results (221-230 of 2,489) with videos related to

Pageof 249
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1984
Pulmonary fate of [3H]bleomycin A2 in miceJ S Lazo, E T Pham
Revista Ecuatoriana De Higiene Y Medicina Tropical|April 1, 1977
[Cirrhotic syndrome in paracoccidioidomycosis]R F Lazo, S Sixto Buenaño
Analytical Biochemistry|February 1, 1980
Solubilization of pulmonary angiotensin-converting enzyme with 1-O-n-octyl-beta-D-glucopyranosideJ S Lazo, D E Quinn
Cancer Treatment Reviews|September 1, 1990
The molecular basis of interstitial pulmonary fibrosis caused by antineoplastic agentsJ S Lazo, D G Hoyt
Cellular and Molecular Life Sciences : CMLS|April 22, 2018
Implication of the VRK1 chromatin kinase in the signaling responses to DNA damage: a therapeutic target?Ignacio Campillo-Marcos, Pedro A Lazo
Biochemical Pharmacology|June 21, 1991
Murine strain differences in pulmonary bleomycin metabolismA E Filderman, J S Lazo
The Orthopedic Clinics of North America|July 7, 2009
Overview of current venous thromboembolism protocols in hip reconstructionAlejandro Lazo-Langner, Marc A Rodger
Current Opinion in Pulmonary Medicine|May 18, 2010
Predicting warfarin doseAlejandro Lazo-Langner, Michael J Kovacs
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1988
Plasma and pulmonary pharmacokinetics of bleomycin in murine strains that are sensitive and resistant to bleomycin-induced pulmonary fibrosisJ H Harrison, J S Lazo
Actas Dermo-Sifiliograficas|March 19, 2010
Therapeutic study of a new arsenical preparation, chlorarsineS LAZO GARCIA, G BLESA LLAMAS
Pageof 249

Showing results (221-230 of 2,489) with videos related to

Sort By:
Pageof 249
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1984
Pulmonary fate of [3H]bleomycin A2 in miceJ S Lazo, E T Pham
Revista Ecuatoriana De Higiene Y Medicina Tropical|April 1, 1977
[Cirrhotic syndrome in paracoccidioidomycosis]R F Lazo, S Sixto Buenaño
Analytical Biochemistry|February 1, 1980
Solubilization of pulmonary angiotensin-converting enzyme with 1-O-n-octyl-beta-D-glucopyranosideJ S Lazo, D E Quinn
Cancer Treatment Reviews|September 1, 1990
The molecular basis of interstitial pulmonary fibrosis caused by antineoplastic agentsJ S Lazo, D G Hoyt
Cellular and Molecular Life Sciences : CMLS|April 22, 2018
Implication of the VRK1 chromatin kinase in the signaling responses to DNA damage: a therapeutic target?Ignacio Campillo-Marcos, Pedro A Lazo
Biochemical Pharmacology|June 21, 1991
Murine strain differences in pulmonary bleomycin metabolismA E Filderman, J S Lazo
The Orthopedic Clinics of North America|July 7, 2009
Overview of current venous thromboembolism protocols in hip reconstructionAlejandro Lazo-Langner, Marc A Rodger
Current Opinion in Pulmonary Medicine|May 18, 2010
Predicting warfarin doseAlejandro Lazo-Langner, Michael J Kovacs
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1988
Plasma and pulmonary pharmacokinetics of bleomycin in murine strains that are sensitive and resistant to bleomycin-induced pulmonary fibrosisJ H Harrison, J S Lazo
Actas Dermo-Sifiliograficas|March 19, 2010
Therapeutic study of a new arsenical preparation, chlorarsineS LAZO GARCIA, G BLESA LLAMAS
Pageof 249